These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Platelet prevention of oxidant lung oedema is not mediated through scavenging of hydrogen peroxide. Godwin JE; Heffner JE Blood Coagul Fibrinolysis; 1992 Oct; 3(5):531-9. PubMed ID: 1450319 [TBL] [Abstract][Full Text] [Related]
8. [Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase]. Lin Y; Sun M Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):259-63. PubMed ID: 8575046 [TBL] [Abstract][Full Text] [Related]
9. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Kikura M; Kazama T; Ikeda T; Sato S Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444 [TBL] [Abstract][Full Text] [Related]
10. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function. Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA Artery; 1993; 20(6):303-13. PubMed ID: 8010886 [TBL] [Abstract][Full Text] [Related]
11. Superoxide, xanthine oxidase and platelet reactions: further studies on mechanisms by which oxidants influence platelets. Levine PH; Sladdin DG; Krinsky NI Thromb Haemost; 1981 Jun; 45(3):290-3. PubMed ID: 6269249 [TBL] [Abstract][Full Text] [Related]
12. Prevention of rapid reperfusion-induced lung injury with prostaglandin E1 during the initial period of reperfusion. DeCampos KN; Keshavjee S; Liu M; Slutsky AS J Heart Lung Transplant; 1998 Nov; 17(11):1121-8. PubMed ID: 9855452 [TBL] [Abstract][Full Text] [Related]
13. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1. Chirkov YY; Chirkova LP; Sage RE; Horowitz JD J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342 [TBL] [Abstract][Full Text] [Related]
14. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets. Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of platelet function by superoxide anion. Handin RI; Karabin R; Boxer GJ J Clin Invest; 1977 May; 59(5):959-65. PubMed ID: 192766 [TBL] [Abstract][Full Text] [Related]
16. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
17. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro. Inoue K; Aoki Y; Kitahara S; Kiyoki M; Araki H Arzneimittelforschung; 1995 Sep; 45(9):975-9. PubMed ID: 7488316 [TBL] [Abstract][Full Text] [Related]
18. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. Tate RM; Morris HG; Schroeder WR; Repine JE J Clin Invest; 1984 Aug; 74(2):608-13. PubMed ID: 6547730 [TBL] [Abstract][Full Text] [Related]
19. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandin releasing polymers - stability and efficacy. McRea JC; Ebert CD; Kim SW Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]